natgillin/translations-raw huggingface dataset:
In order to avoid discrepancies in the high level of protection sought, the inclusion in Annex I to Directive 91/414/EEC was intended to be limited to the uses of carbendazim that have been actually assessed within the Community evaluation and for which the proposed uses were considered to comply with the conditions of Directive 91/414/EEC.
Da bi se izognili odstopanjem v zahtevani visoki stopnji zaščite, je bilo predvideno, da bo vključitev v Prilogo I k Direktivi 91/414/EGS omejena na vrste uporabe karbendazima, ki so bile dejansko ocenjene v okviru ocene Skupnosti, za katere je bilo ocenjeno, da so v skladu s pogoji Direktive 91/414/EGS.
This implies that other uses, which were not or only partially covered by this assessment, had first to be subject to a complete assessment, before their inclusion in Annex I of Directive 91/414/EEC could be considered.
To nakazuje, da je treba za druge vrste uporabe, ki v tej oceni niso bile zajete ali so bile zajete le delno, najprej opraviti celovito oceno, preden se lahko vključijo v Prilogo I k Direktivi 91/414/EGS.
Finally, due to the hazardous nature of carbendazim, it was considered necessary to provide for a minimum harmonisation at Community level of certain risk mitigation measures that were to be applied by Member States when granting authorisations.
Poleg tega se je zaradi nevarne narave karbendazima štelo, da je treba na ravni Skupnosti poskrbeti za minimalno uskladitev nekaterih ukrepov za zmanjšanje tveganja, ki so jih morale države članice izvajati pri podeljevanju registracij.
Under the procedures laid down by Directive 91/414/EEC, the approval of active substances, including the definition of risk management measures, is decided by the Commission.
Na podlagi postopkov iz Direktive 91/414/EGS o odobritvi aktivne snovi, vključno z opredelitvijo ukrepov za obvladovanje tveganja, odloči Komisija.
Member States bear the responsibility for the implementation, application and control of the measures intended to mitigate the risks generated by plant protection products.
Države članice nosijo odgovornost za izvajanje, uporabo in nadzor ukrepov, predvidenih za zmanjšanje tveganja, ki ga ustvarjajo fitofarmacevtska sredstva.
Concerns expressed by several Member States reflect their judgment that additional restrictions are necessary to reduce the risk to a level that can be considered acceptable and consistent with the high level of protection that is sought within the Community.
Zaskrbljenost več držav članic odraža njihovo presojo, da so potrebne omejitve za zmanjšanje tveganja na stopnjo, ki se lahko šteje za sprejemljivo in skladno z zahtevano visoko stopnjo zaščite v Skupnosti.
At present, it is a question of risk management to set the adequate level of safety and protection for the continued production, commercialisation and use of carbendazim.
Trenutno je odvisno od obvladovanja tveganja, da določi ustrezno stopnjo varnosti in zaščite za nemoteno proizvodnjo, komercializacijo in uporabo karbendazima.
In order to correctly reflect the high level of protection of human and animal health and a sustainable environment sought in the Community, it considered appropriate, in addition to the principles set out in Recital 5, to further reduce the period of inclusion to three instead of seven years.
Da bi bila pravilno razvidna visoka stopnja varovanja zdravja ljudi in zdravja živali ter trajnostnega razvoja okolja, za katero si Skupnost prizadeva, se šteje za ustrezno, da se poleg načel iz uvodne izjave 5 nadalje skrajša rok vključitve na tri namesto sedem let.
It may be expected that plant protection products containing carbendazim satisfy the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, with regard to the uses which were examined and detailed in the Commission review report and providing that the necessary risk mitigation measures are applied.
Pričakuje se lahko, da fitofarmacevtska sredstva, ki vsebujejo karbendazim, izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS v zvezi z vrstami uporabe, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu, pod pogojem da se uporabljajo ustrezni ukrepi za zmanjšanje tveganja.
Without prejudice to the conclusion that plant protection products containing carbendazim may be expected to satisfy the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, it is appropriate to obtain further information on certain specific points.
Brez poseganja v sklep, da je od fitofarmacevtskih sredstev, ki vsebujejo karbendazim, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, je ustrezno pridobiti nadaljnje informacije o določenih podrobnostih.
Member States should require authorisation holders to provide information on the use of carbendazim including any information on incidences on operator health.
Države članice bi morale od imetnikov registracij zahtevati, da predložijo informacije o uporabi karbendazima vključno z morebitnimi informacijami o vplivih na zdravje delavcev.
As with all substances included in Annex I to Directive 91/414/EEC, the status of carbendazim could be reviewed under Article 5(5) of that Directive in the light of any new data becoming available.
Tako kot pri vseh snoveh, vključenih v Prilogo I k Direktivi 91/414/EGS, naj bi bilo mogoče status karbendazima pregledati po členu 5(5) navedene direktive na podlagi novih podatkov, ki postanejo dostopni.
In order to avoid further difficulties it therefore appears necessary to clarify the duties of the Member States, especially the duty to verify that the holder of an authorisation demonstrates access to a dossier satisfying the requirements of Annex II to that Directive.
Da bi se izognili nadaljnjim težavam, se zato zdi nujno razjasniti dolžnosti držav članic, zlasti dolžnost, da preverijo, ali ima imetnik registracije dostop do dokumentacije, ki izpolnjuje pogoje iz Priloge II k navedeni direktivi.
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing authorisations of plant protection products containing carbendazim to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should vary, replace or withdraw, as appropriate, existing authorisations. in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti, opredeljene v Direktivi 91/414/EGS kot posledica vključitve aktivne snovi v Prilogo I, je državam članicam treba dovoliti, da v roku 6 mesecev po vključitvi snovi pregledajo obstoječe registracije za fitofarmacevtska sredstva, ki vsebujejo karbendazim, da se zagotovi izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13 Direktive, in ustreznih pogojev iz Priloge I. Po potrebi države članice v skladu z določbami Direktive 91/414/EGS spremenijo, nadomestijo ali prekličejo obstoječe registracije.
Given the hazardous properties of carbendazim, the period for Member States to verify whether the plant protection products, which contain carbendazim as the only active substances or in combination with other authorised active substances, comply with the provisions of Annex VI should not exceed three years.
Zaradi nevarnih lastnosti karbendazima rok, v katerem države članice preverijo, da fitofarmacevtska sredstva, ki vsebujejo karbendazim sam ali v kombinaciji z drugimi registriranimi aktivnimi snovmi, izpolnjujejo zahteve Priloge VI, ne bi smel biti daljši od treh let.
Member States shall adopt and publish by 30 June 2007 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najkasneje do 30. junija 2007.
They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
Komisiji takoj posredujejo besedila teh predpisov in primerjalno tabelo med navedenimi predpisi in direktivo.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing carbendazim as an active substance by 30 June 2007.
Države članice v skladu z Direktivo 91/414/EGS do 30. junija 2007 po potrebi spremenijo ali prekličejo obstoječe registracije za fitofarmacevtska sredstva, ki kot aktivno snov vsebujejo karbendazim.
By that date they shall in particular verify that the conditions in Annex I to that Directive relating to carbendazim are met, with the exception of those identified in part B of the entry concerning that active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13.
Do navedenega datuma zlasti preverijo, ali so izpolnjeni pogoji iz Priloge I k navedeni direktivi v zvezi s karbendazimom, z izjemo tistih iz dela B vpisa, ki se nanaša na navedeno aktivno snov, in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni direktivi v skladu s pogoji iz člena 13.
By derogation from paragraph 1, for each authorised plant protection product containing carbendazim, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning carbendazim.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje karbendazim, v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi, in ob upoštevanju dela B vpisa v Prilogo I k navedeni direktivi, ki se nanaša na karbendazim.
Following that determination Member States shall for products containing carbendazim, where necessary, amend or withdraw the authorisation by 31 December 2009.
Po tej oceni države članice za sredstva, ki vsebujejo karbendazim, registracijo do 31. decembra 2009 po potrebi spremenijo ali prekličejo.
Opinion of the Scientific Committee on Plants (SCP/BENOMY/002 — final, SCP/CARBEN/002 — final, SCP/THIOPHAN/002 — final 002) dated 23 March 2001 regarding the evaluation of benomyl, carbendazim and thiophanate-methyl in the context of Council Directive 91/414/EEC concerning the placing of plant protection products on the market (Opinion adopted by the Scientific Committee on Plants on 7 March 2001).
Mnenje Znanstvenega odbora za rastline (SCP/BENOMY/002 – konč., SCP/CARBEN/002 – konč., SCP/THIOPHAN/002 – konč. 002) z dne 23. marca 2001 v zvezi z oceno benomila, karbendazima in tiofanat-metila v okviru Direktive Sveta 91/414/EGS o dajanju fitofarmacevtskih sredstev v promet (Mnenje, ki ga je Znanstveni odbor za rastline sprejel 7. marca 2001).
Carbendazim (unstated stereochemistry)
Karbendazim (stereokemija ni navedena)
CAS No 10605-21-7
št. CAS 10605-21-7
CIPAC No 263
št. CIPAC 263
Methyl benzimidazol-2-ylcarbamate
Metil benzimidazol-2-ilkarbamat
31 December 2009
december 2009
cereals
žita
rapeseed
oljno repico
sugar beet
sladkorno peso
maize
koruzo
0,25 kg active substance per hectare per application for cereals and rapeseed,
0,25 kg aktivne snovi na hektar ob posamičnem nanosu za žita in oljno repico,
0,075 kg active substance per hectare per application for sugar beet,
0,075 kg aktivne snovi na hektar ob posamičnem nanosu za sladkorno peso,
0,1 kg active substance per hectare per application for maize.
0,1 kg aktivne snovi na hektar ob posamičnem nanosu za koruzo.
earthworms and other soil macro-organisms.
deževnikov in drugih talnih makroorganizmov.
Conditions of authorisation shall include risk mitigation measures, such as the selection of the most appropriate combination of numbers and timing of application, rates of application, and, if necessary, the degree of concentration of the active substance,
Pogoji za registracijo vključujejo ukrepe za zmanjšanje tveganja, kot so izbira najprimernejše kombinacije števila in časa nanosov, pogostnost nanosov in po potrebi koncentracija aktivne snovi,
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on carbendazim, and in particular Appendices I and II thereof, shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za karbendazim in zlasti dodatkov I in II.
Member States may require that elements, such as sales data and a survey of use patterns, are provided so that a realistic picture of the use conditions and the possible toxicological impact of carbendazim can be obtained.’
Države članice lahko zahtevajo navedbo posameznih podrobnosti, kot so podatki o prodaji in pregled vzorcev uporabe, tako da se lahko pridobi stvarna slika o pogojih uporabe in morebitnem toksikološkem učinku karbendazima.“
Commission Directive 2006/136/EC
Direktiva Komisije 2006/136/ES
amending Council Directive 91/414/EEC to include dinocap as active substance
o spremembi Direktive Sveta 91/414/EGS glede vključitve dinokapa kot aktivne snovi
Commission Regulation (EEC) No 3600/92 of 11 December 1992 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market [2] establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I to Directive 91/414/EEC.
Uredba Komisija (EGS) št. 3600/92 z dne 11. decembra 1992 o podrobnih pravilih za izvajanje prve faze delovnega programa iz člena 8(2) Direktive Sveta 91/414/EGS o dajanju fitofarmacevtskih sredstev v promet [2] določa seznam aktivnih snovi fitofarmacevtskih sredstev, ki jih je treba oceniti za morebitno vključitev v Prilogo I k Direktivi 91/414/EGS.
That list includes dinocap.
Ta seznam vključuje dinokap.
For dinocap, the effects on human health and the environment have been assessed in accordance with the provisions laid down in Regulation (EEC) No 3600/92 for a range of uses proposed by the notifier.
Vpliv dinokapa na zdravje ljudi in na okolje je bil predmet presoje v skladu z določbami Uredbe (EGS) št. 3600/92 za vrste uporabe, ki jih je predlagal prijavitelj.
By Commission Regulation (EC) No 933/94 of 27 April 1994 laying down the active substances of plant protection products and designating the Rapporteur Member State for the implementation of Commission Regulation (EEC) No 3600/92 [3], as amended by Regulation (EC) No 491/95 of 3 March 1995 [4], Austria was designated as Rapporteur Member State.
Z Uredbo Komisije (ES) št. 933/94 z dne 27. aprila 1994 o določitvi aktivnih snovi fitofarmacevtskih sredstev in imenovanju držav članic poročevalk za izvajanje Uredbe Komisije (EGS) št. 3600/92 [3], kakor je bila spremenjena z Uredbo (ES) št. 491/95 z dne 3. marca 1995 [4], je bila za državo članico poročevalko imenovana Avstrija.
Austria submitted the relevant assessment report and recommendations to the Commission on 18 May 2000 in accordance with Article 7(1)(c) of Regulation (EEC) No 3600/92.
Avstrija je 18. maja 2000 Komisiji predložila ustrezno poročilo o oceni in priporočila v skladu s členom 7(1)(c) Uredbe (EGS) št. 3600/92.
As regards dinocap, two questions were submitted to the Scientific Panel on Plant Health, Plant Protection Products and their Residues of the European Food Safety Authority (the Scientific Panel).
Glede dinokapa sta bili Znanstvenemu odboru za zdravstveno varstvo rastlin, fitofarmacevtska sredstva in njihove ostanke Evropske agencije za varno hrano (Znanstveni odbor) vloženi dve vprašanji.
The first question concerned the relevance to humans of eye effects that have been observed in dogs and the second related to the appropriate value for dermal absorption that could be derived from the different studies that have been made available by the notifier.
Pri prvem vprašanju je šlo za pomen za ljudi glede posledic na očeh, ki so bile opažene pri psih, in drugo vprašanje je bilo povezano z ustrezno vrednostjo za dermalno absorpcijo, ki izhaja iz različnih študij, ki jih je zagotovil prijavitelj.
On the first question the Scientific Panel considered that there is not sufficient information to conclude that the eye effects in dogs would only be specific to that species and that more research on the mechanisms involved may be necessary.
Glede prvega vprašanja je bil Znanstveni odbor mnenja, da ni zadostnih podatkov, da bi sklepali, da bi bile posledice za oči pri psih specifične za to vrsto in da so potrebne nadaljnje raziskave o zadevnih mehanizmih.
Consequently, it is concluded that these effects in dogs cannot be regarded to be irrelevant to humans.
Zato se sklene, da te posledice pri psih ne morejo veljati za nepomembne za ljudi.
On the second question, the Scientific Panel [5] considered a value of 10 % dermal absorption to be appropriate for the purpose of the assessment.
Glede drugega vprašanja je bil Znanstveni odbor mnenja, da je vrednost 10 % dermalne absorpcije ustrezna za namen ocene.
In both cases, the recommendations of the Scientific Panel have been taken into consideration in formulating this Directive and the relevant review report.
V obeh primerih so bila pri oblikovanju direktive in ustreznega poročila o pregledu upoštevana priporočila Znanstvenega odbora [5].
The original measures presented to the Standing Committee on the Food Chain and Animal Health, proposed the restriction of the inclusion period to seven years, so that Member States would give priority to reviewing plant protection products already on the market containing dinocap.
Prvotni ukrepi, predstavljeni Stalnemu odboru za prehransko verigo ljudi in zdravstveno varstvo živali, predlagajo omejitev obdobja vključitve na sedem let, tako da bi države članice prednostno pregledale fitofarmacevtska sredstva, ki so že na trgu in vsebujejo dinokap.
In order to avoid discrepancies in the high level of protection sought, the inclusion in Annex I to Directive 91/414/EEC was intended to be limited to the uses of dinocap that have been actually assessed within the Community evaluation and for which the proposed uses were considered to comply with the conditions of Directive 91/414/EEC.
Da bi se izognili odstopanjem v zahtevani visoki stopnji zaščite, je bilo predvideno, da bo vključitev v Prilogo I k Direktivi 91/414/EGS omejena na vrste uporabe dinokapa, ki so bile dejansko ocenjene v okviru ocene Skupnosti, za katere je bilo ocenjeno, da so v skladu s pogoji Direktive 91/414/EGS.
Finally, due to the hazardous nature of dinocap, it was considered necessary to provide for a minimum harmonisation at Community level of certain risk mitigation measures that were to be applied by Member States when granting authorisations.
Poleg tega se je zaradi nevarne narave dinokapa štelo, da je treba na ravni Skupnosti poskrbeti za minimalno uskladitev nekaterih ukrepov za zmanjšanje tveganja, ki so jih morale države članice izvajati pri podeljevanju registracij.
At present, it is a question of risk management to set the adequate level of safety and protection for the continued production, commercialisation and use of dinocap.
Trenutno je odvisno od obvladovanja tveganja, da določi ustrezno stopnjo varnosti in zaščite za nemoteno proizvodnjo, komercializacijo in uporabo dinokapa.
In order to correctly reflect the high level of protection of human and animal health and a sustainable environment sought in the Community, it considered appropriate, in addition to the principles set out in recital 5, to further reduce the period of inclusion to three instead of seven years.
Da bi se visoka stopnja zaščite javnega zdravja in zdravja živali ter izbrano trajnostno okolje v Skupnosti pravilno odrazili, se šteje za ustrezno, da se poleg načel, določenih v uvodni izjavi 5, še nadalje zmanjša obdobje vključitve na tri, namesto sedem let.
This further reduces any risk by ensuring the need for a priority reassessment of this substance.
To nadalje zmanjšuje vsako tveganje z zagotovitvijo potrebe po prednostni ponovni oceni te snovi.
It may be expected that plant protection products containing dinocap satisfy the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, with regard to the uses which were examined and detailed in the Commission review report and providing that the necessary risk mitigation measures are applied.
Pričakuje se lahko, da fitofarmacevtska sredstva, ki vsebujejo dinokap, izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS v zvezi z vrstami uporabe, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu, pod pogojem da se uporabljajo ustrezni ukrepi za zmanjšanje tveganja.
Without prejudice to the conclusion that plant protection products containing dinocap may be expected to satisfy the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, it is appropriate to obtain further information on certain specific points.
Brez poseganja v sklep, da je od fitofarmacevtskih sredstev, ki vsebujejo dinokap, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, je ustrezno pridobiti nadaljnje informacije o določenih podrobnostih.
Member States should require authorisation holders to provide information on the use of dinocap including any information on incidences on operator health.
Države članice bi morale od imetnikov registracij zahtevati, da predložijo informacije o uporabi dinokapa vključno z morebitnimi informacijami o vplivih na zdravje delavcev.
As with all substances included in Annex I to Directive 91/414/EEC, the status of dinocap could be reviewed pursuant to Article 5(5) of that Directive in the light of any new data becoming available.
Tako kot pri vseh snoveh, vključenih v Prilogo I k Direktivi 91/414/EGS, naj bi bilo mogoče status dinokapa pregledati po členu 5(5) navedene direktive na podlagi novih podatkov, ki postanejo dostopni.
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing authorisations of plant protection products containing dinocap to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should vary, replace or withdraw, as appropriate, existing authorisations. in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti, opredeljene v Direktivi 91/414/EGS kot posledica vključitve aktivne snovi v Prilogo I, je državam članicam treba dovoliti, da v roku 6 mesecev po vključitvi snovi pregledajo obstoječe registracije za fitofarmacevtska sredstva, ki vsebujejo dinokap, da se zagotovi izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13 Direktive, in ustreznih pogojev iz Priloge I. Po potrebi države članice v skladu z določbami Direktive 91/414/EGS spremenijo, nadomestijo ali prekličejo obstoječe registracije.
Given the hazardous properties of dinocap, the period for Member States to verify whether the plant protection products, which contain dinocap as the only active substances or in combination with other authorised active substances, comply with the provisions of Annex VI should not exceed three years.
Zaradi nevarnih lastnosti dinokapa rok, v katerem države članice preverijo, da fitofarmacevtska sredstva, ki vsebujejo dinokap sam ali v kombinaciji z drugimi registriranimi aktivnimi snovmi, izpolnjujejo zahteve Priloge VI, ne bi smel biti daljši od treh let.